Foreign Policy: WTO Meeting Pits Rich Against Poor In Fight For Vaccines “…South Africa and India are leading a group of low- and middle-income countries calling for a waiver on intellectual property rights on products related to the pandemic — including personal protective equipment, therapeutics, and vaccines. China has also…

Cato Institute: An Unnecessary Proposal: A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines James Bacchus, distinguished university professor of global affairs and director of the Center for Global Economic and Environmental Opportunity at the University of Central Florida and adjunct scholar at the Cato Institute, discusses a proposal…

New York Times: Don’t Fall for Big Pharma’s Savior Act Stephen Buranyi, science journalist and visiting lecturer at the European Business School (12/17). Scientific American: How to Expand Access to COVID Vaccines without Compromising the Science Peter Doshi, associate professor of pharmaceutical health services research at the University of Maryland…

Devex: At WTO, a battle for access to COVID-19 vaccines “High-income countries appear to be maneuvering to avoid a showdown at the World Trade Organization’s General Council meeting, beginning Wednesday, over a proposal to temporarily waive intellectual property protections for all COVID-19 vaccines and other technologies. With the United Kingdom,…

Global Health NOW: A 2-Front Battle: COVID-19 Must Reinvigorate the Fight Against TB Ersin Topcuoglu, director of the USAID-funded Health Systems for Tuberculosis Project at Management Sciences for Health (12/11). IPS: Intellectual Property Monopolies Block Vaccine Access Anis Chowdhury, adjunct professor at Western Sydney University & University of New South…

BMJ Opinion: Covid-19 has turned the spotlight on the uneven provision of oxygen — a stark health inequity Kevin Watkins, CEO of Save the Children U.K., and Adamu Isah, chief of party for the INSPIRING Project at Save the Children Nigeria (12/11). Brookings Institution: The promise and peril of anti-pandemic…

Reuters: WTO delays decision on waiver on COVID-19 drug, vaccine rights “World Trade Organization members on Thursday delayed a decision on a proposal to waive intellectual property rules for COVID-19 drugs and vaccines amid ongoing opposition from wealthy countries, a Geneva trade official said. ‘Big Pharma’ has rejected an idea…

Christian Science Monitor: A critical aspect of the vaccination campaign Editorial Board (12/9). IPS: Human Rights Must Be at the Heart of the COVID-19 Recovery Siddharth Chatterjee, United Nations resident coordinator in Kenya (12/9). New York Times: The Coronavirus Vaccines Were Developed in Record Speed. Now, the Hard Part Editorial…

New York Times: Want Vaccines Fast? Suspend Intellectual Property Rights Achal Prabhala, coordinator of the AccessIBSA project and fellow of the Shuttleworth Foundation; Arjun Jayadev, professor of economics at Azim Premji University and senior economist at the Institute for New Economic Thinking; and Dean Baker, senior economist at the Center…

CNBC: Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine “Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases,…